Anika Therapeutics Inc. short interest in 2026
In 2026, Anika Therapeutics Inc.'s disclosed short interest ran from 4.96% of shares outstanding on 15 Jan 2026 to 2.85% on 15 Sep 2026, a change of -2.11 percentage points. The year's high was 5.30% on 13 Feb 2026 and its low 2.30% on 31 Jul 2026, averaging 3.92% across 17 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 7.87 days on 29 May 2026. Full history: Anika Therapeutics Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2026 in figures
- Start of year
- 4.96% (15 Jan 2026)
- End of year
- 2.85% (15 Sep 2026)
- Change
- -2.11 pp
- High
- 5.30% (13 Feb 2026)
- Low
- 2.30% (31 Jul 2026)
- Average
- 3.92%
- Highest days to cover
- 7.87 (29 May 2026)
- SEC filings marked
- 7
Every report in 2026
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2026 | 4.96% | 5.59 | results (8-K) |
| 30 Jan 2026 | 5.29% | 5.78 | |
| 13 Feb 2026 | 5.30% | 4.36 | |
| 27 Feb 2026 | 5.08% | 5.08 | results (8-K) |
| 13 Mar 2026 | 4.94% | 4.85 | 10-K filed |
| 31 Mar 2026 | 4.77% | 5.47 | |
| 15 Apr 2026 | 4.47% | 4.87 | |
| 30 Apr 2026 | 4.15% | 4.28 | results (8-K), 10-Q filed |
| 15 May 2026 | 4.25% | 5.41 | |
| 29 May 2026 | 4.23% | 7.87 | |
| 15 Jun 2026 | 3.19% | 7.06 | |
| 30 Jun 2026 | 3.13% | 4.89 | |
| 15 Jul 2026 | 2.63% | 4.64 | |
| 31 Jul 2026 | 2.30% | 4.34 | 10-Q filed, results (8-K) |
| 14 Aug 2026 | 2.52% | 2.27 | |
| 31 Aug 2026 | 2.58% | 2.70 | |
| 15 Sep 2026 | 2.85% | 5.36 |
See also: Anika Therapeutics Inc.'s full history · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.